IRONDisc Medicine Inc
IRON
Disc Medicine Inc381
Mkt Cap
$2.55BVolume
399,183.0052W High
$99.5052W Low
$40.00PE Ratio
-11.17IRON Fundamentals
Price
$66.91Prev Close
$65.95Open
$65.9550D MA
$64.82Beta
1.12Avg. Volume
390,483.05EPS (Annual)
-$6.01P/B
3.43Rev/Employee
$0.00$2,042.70
Jennison Associates LLC Takes Position in Disc Medicine, Inc. $IRON
Jennison Associates LLC purchased a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 532,079 shares of the company's stock, valued at approx...
MarketBeat·24h ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc...
PR Newswire·2d ago
Pictet Asset Management Holding SA Grows Stock Holdings in Disc Medicine, Inc. $IRON
Pictet Asset Management Holding SA boosted its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 10,968.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 394,374 shares of the company's stock after acquiring an...
MarketBeat·3d ago
Disc Medicine (IRON) Projected to Post Earnings on Thursday
Disc Medicine (NASDAQ:IRON) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...
MarketBeat·3d ago
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About...
PR Newswire·8d ago
Disc Medicine (NASDAQ:IRON) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Disc Medicine from a "strong sell" rating to a "sell" rating in a research report on Saturday...
MarketBeat·8d ago
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) have received an average recommendation of "Moderate Buy" from the twelve ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assig...
MarketBeat·9d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc...
PR Newswire·17d ago
Disc Medicine (NASDAQ:IRON) Insider Sells $380,423.78 in Stock
Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) insider William Jacob Savage sold 5,731 shares of the firm's stock in a transaction on Monday, April 13th. The shares were sold at an average price...
MarketBeat·17d ago
Jean Franchi Sells 6,257 Shares of Disc Medicine (NASDAQ:IRON) Stock
Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CFO Jean Franchi sold 6,257 shares of the business's stock in a transaction dated Tuesday, April 14th. The shares were sold at an average price of $69.24, for a total value of $433,234.68. Following the completion of the transaction, the chief...
MarketBeat·18d ago
<
1
2
...
>